| 1. |
National Health Commission of the People’s Republic of China. Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version). Chin J Cancer Res, 2019, 31(5): 707-737.
|
| 2. |
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 2006, 355(1): 11-20.
|
| 3. |
Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase Ⅲ trial. J Clin Oncol, 2011, 29(13): 1715-1721.
|
| 4. |
王童博, 毛启坤, 张晓杰, 等. 新辅助治疗行胃癌根治术患者术后并发症及其对预后的影响因素分析. 中华胃肠外科杂志, 2021, 24(2): 160-166.
|
| 5. |
叶建新, 刘声源, 庄金福. 新辅助化疗对进展期胃癌手术并发症的影响. 肿瘤防治研究, 2014, 41(9): 1026-1030.
|
| 6. |
江良县, 周申康, 刘帅, 等. 新辅助化疗联合腹腔镜手术治疗进展期胃癌效果及患者生活质量情况观察. 世界华人消化杂志, 2018, 26(13): 782-789.
|
| 7. |
范朝刚, 李国立. 新辅助化疗对进展期胃癌患者术后肺部感染的影响. 中华胃肠外科杂志, 2011, 14(7): 503-505.
|
| 8. |
Schuhmacher C, Gretschel S, Lordick F, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol, 2010, 28(35): 5210-5218.
|
| 9. |
An JY, Kim KM, Kim YM, et al. Surgical complications in gastric cancer patients preoperatively treated with chemotherapy: their risk factors and clinical relevance. Ann Surg Oncol, 2012, 19(8): 2452-2458.
|
| 10. |
Fujitani K, Ajani JA, Crane CH, et al. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol, 2007, 14(7): 2010-2017.
|
| 11. |
van der Wielen N, Straatman J, Daams F, et al. Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial. Gastric Cancer, 2021, 24(1): 258-271.
|
| 12. |
Li Z, Shan F, Ying X, et al. Assessment of laparoscopic distal gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: a randomized clinical trial. JAMA Surg, 2019, 154(12): 1093-1101.
|
| 13. |
Hayashi M, Yoshikawa T, Yura M, et al. Predictive value of the surgical Apgar score on postoperative complications in advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by radical gastrectomy: a single-center retrospective study. BMC Surg, 2020, 20(1): 150.
|
| 14. |
Xing J, Wang Y, Shan F, et al. Comparison of totally laparoscopic and laparoscopic assisted gastrectomy after neoadjuvant chemotherapy in locally advanced gastric cancer. Eur J Surg Oncol, 2021 Feb 6, Online ahead of print.
|
| 15. |
沈国杰, 朱侃恺, 邬一军, 等. 新辅助化疗联合胃癌根治术治疗进展期胃癌的临床疗效. 中华消化外科杂志, 2017, 16(3): 240-244.
|
| 16. |
Li ZY, Shan F, Zhang LH, et al. Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer. World J Surg Oncol, 2011, 9: 110.
|
| 17. |
崔昊, 张珂诚, 曹博, 等. 进展期胃癌新辅助化疗患者全胃切除术后并发症影响因素分析. 中华胃肠外科杂志, 2021, 24(2): 153-159.
|
| 18. |
Valenti V, Hernandez-Lizoaín JL, Beorlegui MC, et al. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy. J Surg Oncol, 2011, 104(2): 124-129.
|
| 19. |
Wu C, Wang N, Zhou H, et al. Effects of neoadjuvant chemotherapy toxicity and postoperative complications on short-term and long-term outcomes after curative resection of gastric cancer. J Gastrointest Surg, 2020, 24(6): 1278-1289.
|
| 20. |
Yang SJ, Li HR, Zhang WH, et al. Visceral fat area (VFA) superior to BMI for predicting postoperative complications after radical gastrectomy: a prospective cohort study. J Gastrointest Surg, 2020, 24(6): 1298-1306.
|
| 21. |
杨昆, 张维汉, 陈心足, 等. 新辅助治疗大体组织反应评级体系的建立和初步应用. 中华胃肠外科杂志, 2018, 21(9): 1032-1038.
|
